EUVIMEDEUVIMED entdecken
Crossref

Survival outcomes and prognostic factors in surgically resected lung carcinoids: A 25-year retrospective analysis

Luca Bertolaccini, Giovanni Caffarena, Francesca Spada, Lavinia Benini, Eleonora Pisa, Renato Lobrano, Matteo Chiari, Valeria Midolo De Luca, Juliana Guarize, Monica Casiraghi, Nicola Fusco, Nicola Fazio und 1 weitere

European Journal of Surgical Oncology · 2025-10 · 51 (10) · 110366

DOI: 10.1016/j.ejso.2025.110366 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Surgical Oncology, 2025-10. Verfasst von Luca Bertolaccini und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, Milan, Italy. Electronic address: luca.bertolaccini@gmail.com. Hauptthemen laut MEDLINE: Carcinoid Tumor, Lung Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Carcinoids are rare neuroendocrine lung cancers with a prognosis related to stage and grade. Radical and complete surgical resection is the only curative treatment. However, some prognostic factors influencing survival outcomes must be fully understood. This study aims to evaluate the clinical and pathological characteristics of lung carcinoids and identify key predictors of recurrence-free survival and overall survival. METHODS: A retrospective analysis was conducted on patients with histologically confirmed lung carcinoids (typical and atypical) who underwent surgical resection between January 1998 and December 2023. Clinical data, including age, gender, smoking status, tumor laterality, TNM stage, and pathological features, were collected. Survival outcomes were analyzed using Kaplan-Meier curves, log-rank tests, and Cox proportional hazards regression models. RESULTS: The cohort of 524 patients had a median age of 62 years, with 65.6 % females. Most carcinoids were typical (73.7 %) and located on the right side (59.4 %). Advanced tumor stage and higher mitotic counts were significantly associated with poorer survival. No significant impact on survival was observed for surgical techniques or factors such as age, sex, or histology. In particular, laterality shows no statistically significant difference in OS between the two groups (p = 0.35). CONCLUSION: In our extensive series of patients with resected lung carcinoids, tumor stage and mitotic count were critical predictors of survival. While surgical resection is essential, these findings underscore the importance of precise staging and pathological evaluation to inform treatment decisions and enhance patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoid TumorLung NeoplasmsHumansFemaleMaleMiddle AgedRetrospective StudiesPrognosisAgedNeoplasm StagingAdultSurvival RatePneumonectomyAged, 80 and overMitotic IndexKaplan-Meier EstimateProportional Hazards Models

Stichwörter der Autor:innen

Ki-67 indexLung cancerLung neuroendocrine tumorsMitotic countNecrosisTumour location

Autor:innen und Institutionen

  • Department of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, Milan, Italy. Electronic address: luca.bertolaccini@gmail.com.
  • Department of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Division of Neuroendocrine and Digestive Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Division of Interventional Pulmonology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Department of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.

Förderung

  • Ministry of Health

Zitieren

APA

Bertolaccini, L., Caffarena, G., Spada, F., Benini, L., Pisa, E., Lobrano, R., Chiari, M., Midolo De Luca, V., Guarize, J., Casiraghi, M., Fusco, N., Fazio, N., & Spaggiari, L. (2025). Survival outcomes and prognostic factors in surgically resected lung carcinoids: A 25-year retrospective analysis. European Journal of Surgical Oncology, 51(10), 110366. https://doi.org/10.1016/j.ejso.2025.110366

Vancouver

Bertolaccini L, Caffarena G, Spada F, Benini L, Pisa E, Lobrano R, et al. Survival outcomes and prognostic factors in surgically resected lung carcinoids: A 25-year retrospective analysis. European Journal of Surgical Oncology. 2025;51(10):110366. doi:10.1016/j.ejso.2025.110366

BibTeX
@article{Bertolaccini2025,
  author = {Bertolaccini, Luca and Caffarena, Giovanni and Spada, Francesca and Benini, Lavinia and Pisa, Eleonora and Lobrano, Renato and Chiari, Matteo and Midolo De Luca, Valeria and Guarize, Juliana and Casiraghi, Monica and Fusco, Nicola and Fazio, Nicola and Spaggiari, Lorenzo},
  title = {Survival outcomes and prognostic factors in surgically resected lung carcinoids: A 25-year retrospective analysis},
  journal = {European Journal of Surgical Oncology},
  year = {2025},
  volume = {51},
  number = {10},
  pages = {110366},
  doi = {10.1016/j.ejso.2025.110366}
}
Kostenlos starten →